Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone versus sufentanil for bleeding in opioid-addicted patients undergoing cardiac bypass surgery
IRCT20130812014333N103Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of methadone, sufentanil and Placebo-COD Research Private Ltd in opioid use disorder (OUD) and coronary arteriosclerosis (3 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Bleeding rate. Started Sep 2018; status: completed.
02
Drugs
methadonesufentanilPlacebo-COD Research Private Ltd
03
Conditions
opioid use disorder (OUD)coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20130812014333N103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N103.